https://www.selleckchem.com/pr....oducts/eapb02303.htm
The risk of missing orbital cellulitis is low. Young infants with difficult eye examination or the presence of headache or vomiting should increase suspicion of orbital cellulitis. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were approved in August 2015 as an adjunct to maximally tolerated statin treatment in those with familial hypercholesterolemia (FH). To assess PCSK9 inhibitor utilization patterns and cholesterol control in the high-risk FH population. This study was a retrospective analysis of a large adminis
Like
Comment
Share
